CHICAGO, Oct. 26, 2011 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: DuPont (NYSE: DD), UPS (NYSE: UPS), Xerox (NYSE: XRX), 3M (NYSE: MMM) and Texas Instruments (NYSE: TXN).
Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513
Here are highlights from Tuesday's Analyst Blog:
Market to Lift from Positive Earnings?
The market will likely get a lift from a number of positive earnings announcements today, even as it waits for the European deal on Wednesday. Stocks did not take a negative view of the inconclusive weekend Euro-zone summit, but it may not be as charitable if faced with another delay.
The market appears to have priced in some sort of a viable European plan and fresh doubts on that front will likely put a stop to the current market rally. Stocks have made impressive gains this month, up almost 14% since October 3, on rising European hopes and the reassuringly strong quarterly earnings reports.
A number of this morning's earnings reports were particularly reassuring. DuPont (NYSE: DD) handily beat earnings and revenue expectations and guided higher. UPS (NYSE: UPS) came out with a positive earnings surprise on in-line revenue and reiterated its earlier guidance. Xerox (NYSE: XRX) also came ahead of earnings and revenue expectations and reiterated its guidance. 3M (NYSE: MMM) missed expectations and guided lower on weakness in its electronics business, citing economic factors. Texas Instruments (NYSE: TXN) came short of expectations after the close on Monday, citing economic headwinds, and guided lower.
Contrary to some of the more exaggerated concerns about earnings outlooks, the overall tone of earnings reports in this cycle has been positive. With economy no longer a pressing concern, as will likely be confirmed by this week's GDP report, and reassurance on the earnings front, all we need at this stage is a viable enough plan out of Europe.
Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=5515.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=5517
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leon Zacks. As a PhD from MIT Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=5518.
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
SOURCE Zacks Investment Research, Inc.